| Dr Trenton Wallace, | |
|
608 Nw 9th St, #4210, Oklahoma City, OK 73102-1068 | |
| (405) 446-8290 | |
| (405) 601-8298 |
| Full Name | Dr Trenton Wallace |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 16 Years |
| Location | 608 Nw 9th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861633539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 292 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Provider Name | Wallace Foot And Ankle Center,pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336571785 PECOS PAC ID: 4688800584 Enrollment ID: O20131125000948 |
News Archive
New insights into the human immunodeficiency virus (HIV) infection process, which leads to acquired immunodeficiency syndrome (AIDS), may now be possible through a research method recently developed in part at the National Institute of Standards and Technology (NIST), where scientists have glimpsed an important protein molecule's behavior with unprecedented clarity.
Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is usually dramatic, the tumors often recur as the cancer becomes resistant to treatment.
Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published today in the journal Arthritis and Rheumatism.
Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL) - a rare type of non-Hodgkin lymphoma that affects the skin.
› Verified 9 days ago
| Provider Name | Ou Health Partners Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
New insights into the human immunodeficiency virus (HIV) infection process, which leads to acquired immunodeficiency syndrome (AIDS), may now be possible through a research method recently developed in part at the National Institute of Standards and Technology (NIST), where scientists have glimpsed an important protein molecule's behavior with unprecedented clarity.
Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is usually dramatic, the tumors often recur as the cancer becomes resistant to treatment.
Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published today in the journal Arthritis and Rheumatism.
Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL) - a rare type of non-Hodgkin lymphoma that affects the skin.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Trenton Wallace, 608 Nw 9th St, #4210, Oklahoma City, OK 73102-1068 Ph: (405) 446-8290 | Dr Trenton Wallace, 608 Nw 9th St, #4210, Oklahoma City, OK 73102-1068 Ph: (405) 446-8290 |
News Archive
New insights into the human immunodeficiency virus (HIV) infection process, which leads to acquired immunodeficiency syndrome (AIDS), may now be possible through a research method recently developed in part at the National Institute of Standards and Technology (NIST), where scientists have glimpsed an important protein molecule's behavior with unprecedented clarity.
Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is usually dramatic, the tumors often recur as the cancer becomes resistant to treatment.
Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published today in the journal Arthritis and Rheumatism.
Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL) - a rare type of non-Hodgkin lymphoma that affects the skin.
› Verified 9 days ago
Dr. Terry M Nayfa, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3612 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-947-5492 Fax: 405-947-5532 | |
Timothy D Thomas, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. John Andrew Maupin Jr., DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 705 Nw 57th St, Oklahoma City, OK 73118 Phone: 405-550-0060 | |
David G. Wade Dpm Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3330 Nw 56th St, #600, Oklahoma City, OK 73112 Phone: 405-947-8041 | |
Alaina Janae Jones, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. Nicholas B Plants, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9315 S. Pennsylvania Ave, Suite A, Oklahoma City, OK 73159 Phone: 405-691-9004 Fax: 405-691-9003 | |
Peter Quoc Le Podiatrist Medicare: Medicare Enrolled Practice Location: 2201 N Meridian Ave, Oklahoma City, OK 73107 Phone: 405-943-9820 Fax: 405-947-6908 |